8C4 Stock Overview
Researches, develops, produces, sell, leases, and maintains robotic equipment and systems for medical and welfare in Japan, the United States, Europe, the Middle East, Africa, and the Asia Pacific countries.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
CYBERDYNE Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1.10 |
| 52 Week High | JP¥1.61 |
| 52 Week Low | JP¥1.04 |
| Beta | 0.47 |
| 11 Month Change | -4.03% |
| 3 Month Change | -8.21% |
| 1 Year Change | -31.93% |
| 33 Year Change | -62.72% |
| 5 Year Change | -80.94% |
| Change since IPO | -82.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| 8C4 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 4.0% | -6.0% | -1.8% |
| 1Y | -31.9% | -3.5% | 13.2% |
Return vs Industry: 8C4 underperformed the German Medical Equipment industry which returned 0.3% over the past year.
Return vs Market: 8C4 underperformed the German Market which returned 16.1% over the past year.
Price Volatility
| 8C4 volatility | |
|---|---|
| 8C4 Average Weekly Movement | 7.7% |
| Medical Equipment Industry Average Movement | 5.3% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 8C4's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 8C4's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 227 | Yoshiyuki Sankai | www.cyberdyne.jp |
CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains robotic equipment and systems for medical and welfare in Japan, the United States, Europe, the Middle East, Africa, and the Asia Pacific countries. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; Acoustic X, a high-speed light pulse LED array light source that enables real time photoacoustic imaging; and CYIN for living support, which is an interface that uses biological information that can be controlled voluntarily outside of muscle activities. It also provides Cybernics Treatment, a treatment that uses HAL to enhance and regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; Neuro HALFIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes’ brain-nerve functions; and Neuro HALFIT at home for enhancement of physical functions.
CYBERDYNE Inc. Fundamentals Summary
| 8C4 fundamental statistics | |
|---|---|
| Market cap | €238.18m |
| Earnings (TTM) | -€10.83m |
| Revenue (TTM) | €26.93m |
8.8x
P/S Ratio-22.0x
P/E RatioIs 8C4 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8C4 income statement (TTM) | |
|---|---|
| Revenue | JP¥4.46b |
| Cost of Revenue | JP¥2.03b |
| Gross Profit | JP¥2.43b |
| Other Expenses | JP¥4.23b |
| Earnings | -JP¥1.79b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 14, 2024
| Earnings per share (EPS) | -8.50 |
| Gross Margin | 54.44% |
| Net Profit Margin | -40.21% |
| Debt/Equity Ratio | 0.3% |
How did 8C4 perform over the long term?
See historical performance and comparison